These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The non-hematological side effects of levamisole in the treatment of rheumatoid arthritis--a review. Pinals RS J Rheumatol Suppl; 1978; 4():71-5. PubMed ID: 282447 [TBL] [Abstract][Full Text] [Related]
7. High frequency of agranulocytosis in breast-cancer patients treated with levamisole. Teerenhovi L; Heinonen E; Gröhn P; Klefström P; Mehtonen M; Tiilikainen A Lancet; 1978 Jul; 2(8081):151-2. PubMed ID: 78345 [No Abstract] [Full Text] [Related]
8. Immunomodulatory effects of levamisole. Brunner CJ; Muscoplat CC J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1159-62. PubMed ID: 7216893 [TBL] [Abstract][Full Text] [Related]
9. Letter: Levamisole and the immune response. N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358 [No Abstract] [Full Text] [Related]
10. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole]. Vatin AE; Filatov PP Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414 [TBL] [Abstract][Full Text] [Related]
11. [Effect of levamisole on various indicators of cellular immunity in amyloidosis]. Khasabov NN; Mukhin NA; Sura VV; Osipova IN; Varshavskiĭ VA Ter Arkh; 1978; 50(2):115-9. PubMed ID: 644475 [No Abstract] [Full Text] [Related]
12. [Levamisole, a chemically defined substance with immunostimulating potential--a review]. Staber GF Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of levamisole on stromal herpetic keratitis. Sakata H; Yoshida H; Hiyama N; Kondo H; Hirakawa Y Hiroshima J Med Sci; 1983 Dec; 32(4):555-9. PubMed ID: 6678909 [No Abstract] [Full Text] [Related]
14. [Levamisole, an immunostimulant agent]. Schaus R Bull Soc Sci Med Grand Duche Luxemb; 1977 Dec; 114(2):109-11. PubMed ID: 610961 [No Abstract] [Full Text] [Related]
17. [Clinical use of levamisole - perspectives and warnings]. Farber NA Ter Arkh; 1980; 52(1):95-100. PubMed ID: 7368132 [No Abstract] [Full Text] [Related]
18. Restoration of host defense mechanisms in man by levamisole. Brugmans J; Schuermans V; De Cock W; Thienpont D; Janssen P; Verhaegen H; Van Nimmen L; Louwagie AC; Stevens E Life Sci; 1973 Dec; 13(11):1499-504. PubMed ID: 4768979 [No Abstract] [Full Text] [Related]
19. Use of levamisole in Hodgkin's disease. Berényi E; Sonkoly I; Kávai M; Szabolcsi M; Szegedi G N Engl J Med; 1977 Apr; 296(16):941. PubMed ID: 846517 [No Abstract] [Full Text] [Related]
20. [Selected aspects of levamisole use in oncological clinical practice]. Pawlicki M; Stryjewska B; Zarska M Nowotwory; 1979; 29(4):245-51. PubMed ID: 537926 [No Abstract] [Full Text] [Related] [Next] [New Search]